Form4insider filings, from the source

SEC Form 4 · accession 0001012975-18-000059

Acer Therapeutics Inc. · ACER

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
TVM Life Science Ventures VI LP
Director · 10% Owner
Hubert Birner
Director · 10% Owner
Luc Marengere
Director · 10% Owner
Mark Wanless
10% Owner
Gary Leatt
10% Owner
Period of report
Dec 12, 2017
Accepted (ET)
Jan 12, 2018 · 2:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 12, 2017P62,062$12.00A725,844ISee Footnote
Common StockF2Dec 12, 2017P21,271$12.00A248,756ISee Footnote
Common StockF3Dec 12, 2017P250,000$12.00A1,422,709ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses